menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Beyond the Embryonic Stem Cell Debate

close
Beyond the Embryonic Stem Cell Debate
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Although President Obama has favored funding for embryonic stem cell research, the moral debate continues. But that discussion may overshadow the fact that biotech companies have actually made the most early progress, not in embryonic stem cells, but in adult stem cells. Dr. Robert Harman, chief executive officer and founder of Vet-Stem, joins the Chicago Tribune's Bruce Japsen. Vet-Stem is using stem-cell therapy in veterinary regenerative medicine that may one day benefit humans. In this interview, they discuss adult stem cells, and the major momentum in research and commercialized treatments.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Although President Obama has favored funding for embryonic stem cell research, the moral debate continues. But that discussion may overshadow the fact that biotech companies have actually made the most early progress, not in embryonic stem cells, but in adult stem cells. Dr. Robert Harman, chief executive officer and founder of Vet-Stem, joins the Chicago Tribune's Bruce Japsen. Vet-Stem is using stem-cell therapy in veterinary regenerative medicine that may one day benefit humans. In this interview, they discuss adult stem cells, and the major momentum in research and commercialized treatments.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 6/6/20